VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
curodont
Preclinical
Small molecule
A
Ain Shams University
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
White Spot Lesions
Unknown status
Preclinical
Phase 1
Phase 2
Phase 3
Approved
White Spot Lesions
Preclinical
Unknown status
Clinical
Trials by Indication
[1]
White Spot Lesions
1 trial
the Remineralizing Self-Assembling Peptide P11-4, 2% Arginine Enriched Sodium Fluoride and Functionalized Tri Calcium Phosphate Fluoride White Spot Lesions
Unknown status
·
—
·
N/A
·
NCT05127889
·
39 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for curodont. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
curodont compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for curodont. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Ain Shams University company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
A
Ain Shams University
Related News